Genetics of chronic obstructive pulmonary disease

Novartis Foundation Symposium

Volumn 234, Issue , 2001, Pages 45-64

  Silverman, Edwin K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETICS; HUMAN; HUMAN RELATION; REVIEW; RISK FACTOR;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; INTERPERSONAL RELATIONS; LUNG DISEASES, OBSTRUCTIVE; RISK FACTORS;

EID: 0035219153     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (49)

1. Artlich A, Boysen A, Bunge S, Entzian P, Schlaak M, Schwinger E 1995 Common CFTR mutations are not likely to predispose to chronic bronchitis in northern Germany. Hum Genet 95:226-228
2. Bartmann K, Fooke-Achterrath M, Koch G et al 1985 Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Eur J Respir Dis 66:284-296
3. Beaty TH, Liang KY, Seerey S, Cohen BH 1987 Robust inference for variance components models in families ascertained through probands: II. Analysis of spirometric measures. Genet Epidemiol 4:211-221
4. Brandy M, Nukiwa T, Crystal RG 1988 Molecular basis of α-1-antitrypsin deficiency. Am J Med 84:13-31
5. Bruce RM, Cohen BH, Diamond EL 1984 Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am Rev Respir Dis 130:386-390
6. Burrows B, Knudson RJ, Cline MG, Lebowitz MD 1977 Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 115:195-205
7. Celedon JC, Speizer FE, Drazen JM et al 1999 Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD. Eur Respir J 14:1009-1014
8. Cohen BH 1980 Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol 112:274-288
9. Cohen BH, Ball WC Jr, Brashears S et al 1977 Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol 105:223-232
10. Damsgaard T, Kok-Jensen A 1974 Prognosis in severe chronic obstructive pulmonary disease. Acta Med Scand 196:103-108
11. Demenais FM, Bonney GE 1989 Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits. Genet Epidemiol 6:597-617 (erratum 1990 Genet Epidemiol 7:103)
12. Gervais R, Lafitte JJ, Dumur V et al 1993 Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis. Lancet 342:997
13. Gillooly M, Lamb D 1993 Microscopic emphysema in relation to age and smoking habit. Thorax 48:491-495
14. Goate A, Chartier-Harlin M-C, Mullan M et al 1991 Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706
15. Hall JM, Lee MK, Newman B et al 1990 Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689
16. Janoff A 1985 Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 132:417-433
17. Janus ED, Phillips NT, Carrell RW 1985 Smoking, lung function, and α1-antitrypsin deficiency. Lancet 1:152-154
18. Kalsheker NA, Watkins GL, Hill S, Morgan K, Stockley RA, Fick RB 1990 Independent mutations in the flanking sequence of the α-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Markers 8:151-157
19. Kauffmann F, Kleisbauer J-P, Cambon-de-Mouzon A et al 1983 Genetic markers in chronic airflow limitation: a genetic epidemiologic study. Am Rev Respir Dis 127:263-269
20. Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K 1977 Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 63:336-342
21. Larson RK, Barman ML, Kueppers F, Fudenberg HH 1970 Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med 72:627-632
22. 1-antitrypsin deficiency, Pi Z. Acta Med Scand 204:345-351
23. Lieberman J, Winter B, Sastre A 1986 α1-antitrypsin Pi-types in 965 COPD patients. Chest 89:370-373
24. Mahadeva R, Lomas DA 1998 Genetics and respiratory disease. 2. α1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 53:501-505
25. Morse JO, Lebowitz MD, Knudson RJ, Burrows B 1977 Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 296:1190-1194
26. Novoradovsky A, Brantly ML, Waclawiw MA et al 1999 Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in α1-antitrypsin deficiency. Am J Respir Cell Mol Biol 20:441-447
27. O'Donnell DE, Webb KA 1992 Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest 102:824-831
28. Poller W, Faber JP, Scholz S et al 1992 Mis-sense mutation of α1-antichymotrypsin gene associated with chronic lung disease. Lancet 339:1538
29. Postma DS, Burema J, Gimeno F et al 1979 Prognosis in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 119:357-367
30. Redline S, Tishler PV, Rosner B et al 1989 Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 129:827-836
31. Rybicki BA, Beaty TH, Cohen BH 1990 Major genetic mechanisms in pulmonary function. J Clin Epidemiol 43:667-675
32. Sandford AJ, Spinelli JJ, Weir TD, Paré PD 1997 Mutation in the 3′ region of the α-1-antitrypsin gene and chronic obstructive pulmonary disease. J Med Genet 34:874-875
33. Sandford AJ, Chagani T, Weir TD, Paré PD 1998 α1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers 13:257-260
34. Sandford AJ, Weir TD, Spinelli JJ, Paré PD 1999 Z and S mutations of the α1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 20:287-291
35. Schellenberg D, Paré PD, Weir TD, Spinelli JJ, Walker BA, Sandford AJ 1998 Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 157:957-961
36. Seersholm N, Kok-Jensen A, Dirksen A 1995 Decline in FEV1 among patients with severe hereditary α1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 152:1922-1925
37. Silverman EK, Miletich JP, Pierce JA et al 1989a α-1-antitrypsin deficiency. High prevalence in the St Louis area determined by direct population screening. Am Rev Respir Dis 140:961-966
38. Silverman EK, Pierce JA, Province MA, Rao DC, Campbell EJ 1989b Variability of pulmonary function in α1-antitrypsin deficiency: clinical correlates. Ann Intern Med 111:982-991
39. Silverman EK, Province MA, Campbell EJ, Pierce JA, Rao DC 1992 Family study of α1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits. Genet Epidemiol 9:317-331
40. Silverman EK, Chapman HA, Drazen JM et al 1998 Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157:1770-1778
41. Silverman EK, Weiss ST, Drazen JM et al 2000 Gender differences in severe, early onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med, in press
42. Stone EM, Fingert JH, Alward WLM et al 1997 Identification of a gene that causes primary open angle glaucoma. Science 275:668-670
43. Tobin MJ, Cook PJL, Hutchison DC 1983 α1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 77:14-27
44. Travis J, Salvesen GS 1983 Human plasma proteinase inhibitors. Annu Rev Biochem 52:655-709
45. Vestbo J, Hein HO, Suadicani P, Soørensen H, Gyntelberg F 1993 Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male Study. Dan Med Bull 40:378-380
46. Vionnet N, Stoffel M, Takeda J et al 1992 Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356:721-722
47. Wegner RE, Jörres RA, Kirsten DK, Magnussen H 1994 Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 7:725-729
48. Wooster R, Neuhausen S, Mangion J et al 1994 Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13q12-13. Science 265:2088-2090
49. Yamada N, Yamaya M, Okinaga S et al 2000 Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66:187-195